The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -4,678 | -172 |
| Depreciation and amortization | 6 | 12 |
| Write-off of intangible assets | 0 | 174 |
| Share based compensation | 34 | 6 |
| Change in fair value of convertible loans and warrant liability and financial expenses, net | -3,994 | 314 |
| Financial expenses, net | -2 | 10 |
| Other expenses | 445 | - |
| Other accounts receivables | 18 | -8 |
| Inventory | 8 | 32 |
| Accounts payable | 1 | 11 |
| Accounts payables related party | 89 | 84 |
| Net cash used in operating activities | -137 | -213 |
| Research and development expenses capitalization | - | 1 |
| Net cash used in investing activities | - | -1 |
| Proceeds from issuance of common stock | 611 | 124 |
| Net cash provided by financing activities | 611 | 124 |
| Foreign exchange on cash and cash equivalents | -15 | 19 |
| Change in cash and cash equivalents | 460 | -71 |
| Cash and cash equivalents at beginning of period | 79 | - |
| Cash and cash equivalents at end of period | 468 | - |
APPYEA, INC (APYP)
APPYEA, INC (APYP)